CD274 and non-small cell lung carcinoma: Therefore, in the current study we evaluated, via cutting-edge spatial profiling and immunostaining, PD-L1 expression in AMs from patients with COPD, NSCLC, and ever- or never- smoker controls in vivo and tested the effects of CS on AMs from each patients’ group in vitro.